Follow
Dr. Prajwal Nandekar
Dr. Prajwal Nandekar
Ph. D
Verified email at h-its.org - Homepage
Title
Cited by
Cited by
Year
Impact of crystal habit on biopharmaceutical performance of celecoxib
SR Modi, AKR Dantuluri, V Puri, YB Pawar, P Nandekar, AT Sangamwar, ...
Crystal growth & design 13 (7), 2824-2832, 2013
882013
Ensemble docking and molecular dynamics identify knoevenagel curcumin derivatives with potent anti-EGFR activity
IS Yadav, PP Nandekar, S Shrivastava, A Sangamwar, A Chaudhury, ...
Gene 539 (1), 82-90, 2014
682014
Structure guided design and binding analysis of EGFR inhibiting analogues of erlotinib and AEE788 using ensemble docking, molecular dynamics and MM-GBSA
VK Sharma, PP Nandekar, A Sangamwar, H Pérez-Sánchez, SM Agarwal
RSC advances 6 (70), 65725-65735, 2016
512016
Benchmarking refined and unrefined AlphaFold2 structures for hit discovery
Y Zhang, M Vass, D Shi, E Abualrous, JM Chambers, N Chopra, C Higgs, ...
Journal of Chemical Information and Modeling 63 (6), 1656-1667, 2023
402023
Inter-subunit interactions drive divergent dynamics in mammalian and Plasmodium actin filaments
RG Douglas, P Nandekar, JE Aktories, H Kumar, R Weber, JM Sattler, ...
PLoS biology 16 (7), e2005345, 2018
392018
An ecofriendly synthesis and DNA binding interaction study of some pyrazolo [1, 5-a] pyrimidines derivatives
SS Chobe, BS Dawane, KM Tumbi, PP Nandekar, AT Sangamwar
Bioorganic & medicinal chemistry letters 22 (24), 7566-7572, 2012
352012
Influence of transmembrane helix mutations on cytochrome P450-membrane interactions and function
G Mustafa, PP Nandekar, TJ Camp, NJ Bruce, MC Gregory, SG Sligar, ...
Biophysical journal 116 (3), 419-432, 2019
322019
Plasma protein binding, pharmacokinetics, tissue distribution and CYP450 biotransformation studies of fidarestat by ultra high performance liquid chromatography–high resolution …
RM Borkar, MM Bhandi, AP Dubey, PP Nandekar, AT Sangamwar, ...
Journal of pharmaceutical and biomedical analysis 102, 386-399, 2015
322015
Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings
PP Nandekar, AT Sangamwar
Expert opinion on drug discovery 7 (9), 771-789, 2012
292012
Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design
X Yu, P Nandekar, G Mustafa, V Cojocaru, GI Lepesheva, RC Wade
Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (1), 67-78, 2016
282016
The effect of force-field parameters on cytochrome P450-membrane interactions: structure and dynamics
G Mustafa, PP Nandekar, G Mukherjee, NJ Bruce, RC Wade
Scientific reports 10 (1), 7284, 2020
262020
An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase
G Mukherjee, PP Nandekar, RC Wade
Communications Biology 4 (1), 55, 2021
242021
On the application of the MARTINI coarse-grained model to immersion of a protein in a phospholipid bilayer
G Mustafa, PP Nandekar, X Yu, RC Wade
The Journal of Chemical Physics 143 (24), 2015
242015
Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction
PD Kalariya, B Raju, RM Borkar, D Namdev, S Gananadhamu, ...
Journal of mass spectrometry 49 (5), 380-391, 2014
232014
Human pregnane X receptor: a novel target for anticancer drug development
V Rathod, S Jain, P Nandekar, AT Sangamwar
Drug Discovery Today 19 (1), 63-70, 2014
232014
Chem-bioinformatics and in vitro approaches for candidate optimization: a case study of NSC745689 as a promising antitumor agent
PP Nandekar, KM Tumbi, N Bansal, VP Rathod, LB Labhsetwar, ...
Medicinal Chemistry Research 22, 3728-3742, 2013
222013
Pregnane X receptor and P-glycoprotein: a connexion for Alzheimer’s disease management
S Jain, V Rathod, R Prajapati, PP Nandekar, AT Sangamwar
Molecular diversity 18 (4), 895-909, 2014
212014
Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations
SS Kesharwani, PP Nandekar, P Pragyan, V Rathod, AT Sangamwar
Journal of Molecular Recognition 29 (8), 370-390, 2016
202016
Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations
P Pragyan, SS Kesharwani, PP Nandekar, V Rathod, AT Sangamwar
Molecular diversity 18 (4), 865-878, 2014
202014
Mechanistic insights into PEPT1-mediated transport of a novel antiepileptic, NP-647
KS Khomane, PP Nandekar, B Wahlang, P Bagul, N Shaikh, YB Pawar, ...
Molecular pharmaceutics 9 (9), 2458-2468, 2012
182012
The system can't perform the operation now. Try again later.
Articles 1–20